Clinical Trials Offer Hope

On the Horizon. As the first academic and clinical research enterprise in Nevada, Renown Health and the University of Nevada, Reno School of Medicine partner to provide access to the region’s most advanced clinical trials. Our Office of Clinical Research supports numerous research efforts in various specialties and actively seeks new collaborations. Dozens of open clinical trials, including these, are currently underway at Renown Health.

Genetics

STUDY TITLE: M/NASH
Full protocol title: Nonalcoholic Steatohepatitis Liver Disease Genome Atlas Indication: Metabolic and nonalcoholic steatohepatitis
Phase: II
PI name: Joseph Grzymski, PhD
Phone number: 775-982-6914

Oncology

STUDY TITLE: EXAI CP-23001
Full protocol title: A Prospective Study of oncRNA Stratification of Cancer by Size and Stage
Indication: multi-disease site cancer stratification by size and stage & healthy controls
NCT number: NCT05833360
Phase: Not Applicable
PI name: Lee Schwartzberg, MD
Phone number: 775-982-5050

Pediatrics

STUDY TITLE: VAD00004 (PEARL)
Full protocol title: Efficacy, Immunogenicity, and Safety Study of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers
Indication: Respiratory syncytial virus (RSV)
NCT number: NCT06252285
Phase: II
PI name: Sonia Budhecha, MD
Phone number: 775-982-3646

Pulmonology

STUDY TITLE: PROACT-LUNG
Full protocol title: The PROACT LUNG Study: A Prospective, Observational, Clinical Validation Study of the Freenome Multiomics Blood Test for Lung Cancer Screening (FRNM-007)
Indication: Lung cancer
NCT number: 06122077
Phase: Observational
PI name: Farah Madhani Lovely, MD
Phone number: 775-982-7532

Rheumatology

STUDY TITLE: TOPAZ-2 230LE304
Full protocol title: A Multicenter, Randomized, Double-Blind, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Litifilimab (BIIB059) in Adult Participants With Active Systemic Lupus Erythematosus Receiving Background Nonbiologic Lupus Standard of Care
Indication: Systemic lupus erythematosus (SLE)
NCT number: 04961567
Phase: IIII
PI name: Kennedy Ukadike, MD
Phone number: 775-982-6128

Click here to learn more about open Clinical Trials available at Renown Health.